Advertisement
Research Article

X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis

  • Cathleen D. Valentine,

    Affiliation: Department of Nephrology, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Marc O. Anderson,

    Affiliation: Department of Chemistry and Biochemistry, San Francisco State University, San Francisco, California, United States of America

    X
  • Feroz R. Papa,

    Affiliation: Lung Biology Center, Diabetes Center, and California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Peter M. Haggie mail

    peter.haggie@ucsf.edu

    Affiliation: Department of Nephrology, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Published: August 22, 2013
  • DOI: 10.1371/journal.ppat.1003576

Abstract

Pseudomonas aeruginosa infections are associated with high mortality rates and occur in diverse conditions including pneumonias, cystic fibrosis and neutropenia. Quorum sensing, mediated by small molecules including N-(3-oxo-dodecanoyl) homoserine lactone (C12), regulates P. aeruginosa growth and virulence. In addition, host cell recognition of C12 initiates multiple signalling responses including cell death. To gain insight into mechanisms of C12-mediated cytotoxicity, we studied the role of endoplasmic reticulum stress in host cell responses to C12. Dramatic protection against C12-mediated cell death was observed in cells that do not produce the X-box binding protein 1 transcription factor (XBP1s). The leucine zipper and transcriptional activation motifs of XBP1s were sufficient to restore C12-induced caspase activation in XBP1s-deficient cells, although this polypeptide was not transcriptionally active. The XBP1s polypeptide also regulated caspase activation in cells stimulated with N-(3-oxo-tetradecanoyl) homoserine lactone (C14), produced by Yersinia enterolitica and Burkholderia pseudomallei, and enhanced homoserine lactone-mediated caspase activation in the presence of endogenous XBP1s. In C12-tolerant cells, responses to C12 including phosphorylation of p38 MAPK and eukaryotic initiation factor 2α were conserved, suggesting that C12 cytotoxicity is not heavily dependent on these pathways. In summary, this study reveals a novel and unconventional role for XBP1s in regulating host cell cytotoxic responses to bacterial acyl homoserine lactones.

Author Summary

Chronic and acute infections associated with P. aeruginosa constitute a major healthcare burden. Antimicrobial approaches are currently used against P. aeruginosa; however, infections are typically refractory to treatment and drug resistant strains have been isolated. As such, there is urgent need to understand mechanisms of P. aeruginosa virulence and for new strategies to fight infections. The P. aeruginosa-derived quorum-sensing molecule C12 is recognized by host cells and initiates stress responses including cytotoxicity. In this study, the X-box binding protein 1 transcription factor (XBP1s) was identified as a host factor critical for apoptotic responses initiated by C12 and other similar quorum sensing molecules. Additional C12-initiated host responses, including phosphorylation of p38 MAPK and eIF2α were found to be of lesser importance for C12-initiated cytotoxicity. These studies have broad implications for our understanding of bacterial virulence mechanisms and for development of potential new strategies to combat infections.

Introduction

Pseudomonas aeruginosa is an opportunistic bacterium and infections caused by this pathogen constitute a significant heath-care burden. P. aeruginosa is the fourth most-commonly isolated nosocomial pathogen and infections can be fatal, particularly in immuno-compromised subjects such as those with burns or undergoing chemotherapy [1], [2], [3], [4]. Chronic conditions including cystic fibrosis (CF), chronic obstructive pulmonary disease, acquired immunodeficiency syndrome, and non-CF bronchiectasis are also associated with P. aeruginosa infection [5], [6], [7]. Antimicrobials are currently used against P. aeruginosa; however, infections are typically refractory to therapeutic interventions [8]. Furthermore, drug resistant P. aeruginosa strains have been isolated and biofilm formation in chronic conditions enhances antimicrobial resistance and pathogenicity [9], [10]. As such, there is urgent need to understand mechanisms of P. aeruginosa virulence and for new strategies to combat infections [10], [11].

The process of quorum sensing (QS) has evolved as a mechanism by which bacterial communities sense cell density and consequently regulate processes such as growth, biofilm formation and expression of virulence factors [12], [13]. Bacteria synthesize small, diffusible molecules to coordinate QS and a major signal generated by P. aeruginosa is N-(3-oxo-dodecanoyl) homoserine lactone (C12, Figure 1A). In addition to regulating P. aeruginosa responses, C12 activates host cell responses via a process termed inter-kingdom signalling [14]. C12 is cytotoxic in a dose dependent manner in macrophages, neutrophils, fibroblasts and epithelial cells [15], [16], [17], [18]. Additional C12-activated host responses include phosphorylation of p38 mitogen activated protein kinase (MAPK), phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) and synthesis of c-jun mRNA [17]. C12 represses transcriptional activation of nuclear factor κ-light chain-enhancer of activated B cells (NF-κB) -responsive genes in stimulated macrophages, T-cells and fibroblasts [19], [20], [21]. In contrast, C12 has also been reported to intrinsically activate pro-inflammatory responses, including elevation of prostaglandin E2 and cyclooxygenase 2 levels, in certain cell types [22], [23]. Finally, C12 affects calcium homeostasis by releasing calcium stores from the endoplasmic reticulum (ER) [18], [24], [25].

thumbnail

Figure 1. Deletion of Ire1α prevents C12 cytotoxicity.

A. Structure of the Pseudomonas aeruginosa N-(3-oxo-dodecanoyl) homoserine lactone (C12). B. (left) Cell density of wt (wild-type; first panels), Perk−/− (third panels) and Ire1α−/− (fourth panels) MEFs under control conditions (top) and after C12 challenge (25 µM, 4 hours, bottom) assessed by calcein AM labelling. Caspase inhibition prevents C12 cytotoxicity as assessed by calcein AM staining of z-VAD-fmk (z-VAD) treated wt MEFs cells (second panels). (right) RT-PCR (top) and western blot (bottom) analysis of Perk−/− and Ire1α−/− MEFs. C. Quantitative analysis of change in MEF cell density after C12 challenge in wt, Perk−/− and Ire1α−/− MEFs and in z-VAD-fmk-treated wt MEFs (grey bar). D. Normalized caspase 3/7 activity in wt, Perk−/− and Ire1α−/− MEFs in control conditions (−) and after C12 treatment (+; 25 µM, 4 hours). E. Dose response of normalized caspase 3/7 activity in wt MEFs treated with C12 for 4 hours. Statistical analysis was by t-test with reference to data from wt MEFs (C) or control experiments (E); * p<0.005, ** p<0.0001.

doi:10.1371/journal.ppat.1003576.g001

Knowledge of how host cells recognize and respond to C12 is incomplete, although it is believed that C12 may interact with multiple host targets in a cell-type dependent manner [14]. The bitter taste receptor T2R38 was recently demonstrated to recognize C12 [26]. Stimulation of T2R38 by C12 activates mucociliary clearance and nitric oxide production to facilitate bacterial clearance and killing in primary airway epithelial cultures [26]. Polymorphisms in the T2R38 gene associated with Gram-negative sinonasal infections were demonstrated to reduce airway responsiveness to C12 indicating that C12–host interactions are pathologically relevant [26]. C12 is cell permeable and members of the peroxisome proliferator-activated receptor nuclear hormone receptor family have been proposed to respond to C12 [27]. In contrast, it has been suggested that C12 and other similar acyl homoserine lactones interact directly with host cell membranes to alter membrane polarity and consequently mediate cellular responses [28]. Although innate immune system receptors are capable of recognizing diverse pathogen-derived molecules, Toll-like receptors (TLRs) and the nucleotide-binding, oligomerization domain (NOD)-like receptors Nod1 and Nod2 are not required for C12 recognition [17].

The overall objective of this study was to gain insight into how C12 causes cell death. Several C12-induced cellular responses, including morphological changes to ER structure, phosphorylation of eIF2α and disruption of calcium homeostasis, are characteristic of ER stress [17], [24], [25]. ER stress typically activates intrinsic apoptosis [29], [30] and additional C12-initiated responses including cytochrome c release, mitochondrial depolarization and caspase 9 activation, suggest that this pathway is involved in C12 cytotoxicity [17], [18], [25]. As such, we tested the hypothesis that ER stress initiates C12-mediated cell death. Unexpectedly, these studies identified the X box-binding protein 1 transcription factor (XBP1s) as a major regulator of C12-mediated cell death. In this study, we report that: (i) XBP1s regulates C12 cytotoxicity by a novel, non-transcriptional mechanism; (ii) XBP1s mediates cellular responses to C12 and similar acyl homoserine lactones in a cell type-independent manner and; (iii) C12-mediated cellular responses occur via XBP1s-dependent and independent pathways.

Results

Deletion of inositol-requiring enzyme 1α is protective against C12-mediated cell death

Three sensors monitor ER protein folding stress; PERK (protein kinase RNA-like ER kinase), IRE1α (inositol-requiring enzyme 1α) and ATF6 (activating transcription factor 6) [30], [31]. Of these sensors, PERK and IRE1α have been associated with ER stress-activated apoptotic responses [31], [32], [33]. Therefore, to investigate the role of ER stress response pathways in C12 cytotoxicity, wild type (wt) murine embryonic fibroblasts (MEFs) and knockout MEFs that do not express PERK (Perk−/−) or IRE1α (Ire1α−/−) were challenged with C12 and cytotoxic responses characterized. Significant cell death was observed in C12-treated wt MEFs (~40% at 4 hours), as assessed by comparison of cell labelling with the supravital dye calcein before and after C12-treatment (Figure 1B, first panels, and Figure 1C). The response of Perk−/− MEFs to C12 was similar to that in wt MEFs indicating that C12 cytotoxicity is not dependent upon PERK activity (Figure 1B, third panels, and Figure 1C). In contrast, Ire1α−/− MEFs were resistant to C12 cytotoxicity suggesting that C12-induced cell death is IRE1α-dependent (Figure 1B, fourth panels, and Figure 1C). RT-PCR and western blot analysis was performed to verify the identity of knockout cell lines used in these studies (Figure 1B, right).

Caspase (cysteine-dependent aspartate-directed protease) activation has previously been implicated in C12-mediated cell death [17], [18]; however, caspases have not definitively been demonstrated to mediate C12 cytotoxicity. As such, caspase activity in C12-challenged MEFs was characterized to further investigate the mechanism of C12 cytotoxicity. In wt MEFs, the pan-caspase inhibitor z-VAD-fmk inhibited C12-cytotoxicity (~90% cells remained at 4 hours) suggesting that cell death requires caspase activation (Figure 1B, second panels and Figure 1C, grey bar). Several families of cysteine proteases can be inhibited by z-VAD-fmk; however, inhibition of cathepsin B (CA-074-Me) or calpain (ALLN) did not reduce C12 toxicity in wt MEFs (Figure S1A). As such, z-VAD-fmk effects in C12-treated MEFs were caspase specific and C12 cytotoxicity is dependent upon caspase activation. Direct measurements of executioner caspase (caspase 3 and 7) activity in MEF cell lines stimulated with 25 µM C12 indicated that Ire1α deletion dramatically reduced caspase activation relative to wt and Perk−/− MEFs (Figure 1D). Reported concentrations of C12 in liquid culture and biofilms vary from 5 to 600 µM [21], [34]; therefore, we assessed caspase activation in wt MEFs in response to low C12 concentrations (Figure 1E and Figure S1B). Executioner caspase activation was significantly enhanced by 4 hour treatment with low C12 concentration (5 µM and 10 µM C12 produced ~2-fold and ~5-fold increases respectively) and progressively increased with higher C12 doses. Taken together, these studies indicate that C12-cytotoxicity in MEFs: (i) requires caspases such that cell death can formally be classified as apoptosis, (ii) is highly dependent on IRE1α activity and, (iii) is independent of PERK activity.

IRE1α deletion indirectly prevents C12 apoptosis

IRE1α is a transmembrane protein that resides in the ER and contains cytoplasmic kinase and endoribonuclease (RNase) activities [30], [35]. During homeostatic conditions, IRE1α RNase activity is limited, although it does mediate sequence specific, non-conventional splicing of a pre-mRNA (Xbp1u) to generate mature mRNA (Xbp1s) that encodes the X-box binding protein 1 transcription factor (XBP1s) [30], [33], [35]. Xbp1u pre-mRNA also encodes XBP1u protein that binds to and regulates XBP1s stability [36]; the internal location of the Xbp1u splice site dictates that XBP1u and XBP1s share a common amino terminus. During periods of irremediable ER stress, as observed in pathological conditions such as neurodegeneration and type II diabetes, IRE1α becomes hyper-activated leading to apoptosis driven by promiscuous IRE1α RNase activity and/or activation of apoptosis signal-regulating kinase 1 (ASK1) and its downstream target c-jun NH2-terminal kinase (JNK) [33], [37], [38], [39].

Treatment of wt MEFs with STF-083010, a selective and irreversible inhibitor of IRE1α RNase activity [39], [40], did not inhibit C12-mediated toxicity or caspase 3/7 activation (Figure 2A, left and Figure 2B). Similarly, treatment of wt MEFs with a JNK inhibitor (SP600125) did not reduce C12 cytotoxicity (Figure 2A, right) or activation of caspase 3/7 (Figure S1C). A prerequisite for IRE1α-mediated apoptotic signalling is IRE1α activation, a process that involves oligomerization and trans-autophosphorylation [33], [37]. Therefore, to further investigate a possible role of IRE1α in C12-mediated cytotoxic responses, IRE1α activity was directly assessed using a luciferase-based reporter (XBP1-luc). The XBP1-luc reporter encodes cDNA containing the Xbp1u pre-mRNA splice site fused upstream of a luciferase gene ([41], see also MATERIALS AND METHODS). In the absence of IRE1α activity, an ‘in-frame’ stop codon prevents luciferase expression (Figure 2C, top left); however, upon IRE1α-mediated pre-mRNA splicing (which removes 26 nucleotides), the stop codon is shunted ‘out-of-frame’ and luciferase is expressed to report IRE1α activity (Figure 2C, bottom left). In wt MEFs expressing XBP1-luc, IRE1α activity was not increased above control levels after 2 hours of C12 stimulation (Figure 2C, right). In contrast, exposure of cells to thapsigargin, a known ER stress-inducing agent, produced significant enhancement of IRE1α activity over the same time frame (Figure 2C, right). Treatment of wt MEFs for 2 hours with C12 or thapsigargin produced relatively little cell loss (<10%, Figure S1A). Data obtained in an additional cell type suggested that the absence of significant IRE1α activation in response to C12 stimulation is a generalized phenomenon (Figure S1D). In summary, these studies: (i) provide pharmacological evidence that IRE1α is not directly involved in C12-mediated cytotoxicity and, (ii) demonstrate that C12 stimulation of cells does not significantly activate the IRE1α ER stress sensor.

thumbnail

Figure 2. Absence of the XBP1s transcription factor is responsible for reduced C12 cytotoxicity.

A. Fluorescence images of calcein AM stained wt MEFs treated with inhibitors of IRE1α RNase activity (STF-080310) and JNK (SP600125) in control conditions (top) and with C12 (25 µM, 4 hours, bottom). B. Normalized caspase 3/7 activation in wt MEFs in control conditions (black) and after treatment with STF-083010 (grey). C. Assessment of IRE1α activation in C12-treated cells. (left) Schematic of luciferase-based IRE1α activity reporter. Luciferase (luc) expression is prevented under control conditions by an ‘in-frame’ stop codon (top); however, IRE1α activation results in non-conventional splicing and removal of 26 nucleotides (26 nt) from the reporter pre-mRNA which shunts the stop codon ‘out-of-frame’ and the luciferase ‘in-frame’ (bottom). (right) IRE1α activation in wt MEFs in control conditions (black) and after 2 hours treatment with 25 µM C12 (grey) or 250 nM thapsigargin (blue). Statistical analysis was by ANOVA with Dunnett post hoc test; ** p<0.0001 versus control cells. D. Deletion of Xbp1 prevents C12-cytotoxicity assessed by calcein AM labelling (left) and caspase 3/7 activation (right). (bottom) Analysis of Xbp1−/− MEF by RT-PCR and western blot. E. Analysis of time- (left) and dose-dependent (right) C12-mediated normalized caspase 3/7 activation in wt (black) and Xbp1−/− (grey) MEFs. Cells were treated with 25 µM C12 over 0–8 hours and for 4 hours with 0–100 µM C12. Scale bar in panel A refers to all images.

doi:10.1371/journal.ppat.1003576.g002

Ire1α−/− MEFs synthesize Xbp1u pre-mRNA; however, Xbp1u splicing and XBP1s protein are undetectable in this cell type indicating that IRE1α is uniquely responsible for processing of Xbp1u pre-mRNA in MEFs ([33], [42], see also Figure S2A). As such, C12 cytotoxic responses were assessed directly in Xbp1−/− MEFs to test the hypothesis that reduced C12 cytotoxicity in Ire1α−/− MEFs results from loss of XBP1s function(s). C12 stimulation of Xbp1−/− MEFs produced little apparent reduction in cell density (Figure 2D, left) and dramatically reduced activation of executioner caspases relative to wt MEFs (Figure 2D, right). The identity of Xbp1−/− MEFs used in these studies was confirmed by RT-PCR and western blot analysis (Figure 2D, bottom). Additional experiments were performed to characterize the apparent tolerance of Xbp1−/− MEFs to C12 cytotoxicity. Treatment of wt MEFs with C12 produced time- and dose-dependent increases in caspase 3/7 activity, similar to observations made in other cell types [15], [16], [17], [18] (Figure 2E, black bars). In contrast, caspase 3/7 activation only increased by ~2–4-fold in Xbp1−/− MEFs stimulated with 25 µM C12 for up to 8 hours or with C12 concentrations increasing to 100 µM (Figure 2E, grey bars). Similar results were obtained in Ire1α−/− MEFs although control experiments verified that levels of executioner caspases in Xbp1−/− and Ire1α−/− MEFs were similar to those in wild type cells (Figure S1E and data not shown). As such, these studies indicate that C12 cytotoxicity requires the presence of XBP1s and that reduced levels of the XBP1s do not merely alter the kinetics or sensitivity of cellular responses to C12.

To investigate whether XBP1s loss-of-function was directly responsible for C12 tolerance, Xbp1−/− and Ire1α−/− MEFs were transiently transfected with Xbp1 cDNA and responses to C12 were characterized. As predicted from direct measurement of executioner caspase activation, treatment of wt MEFs with C12 produced robust caspase 3-cleavage that could be detected by immunostaining (Figure 3A). Similarly, as expected from measurements of executioner caspase activity, cleaved caspase 3 was essentially absent in C12-stimulated Xbp1−/− and Ire1α−/− MEFs (Figure 3B and C, left panels). Transfection of Xbp1−/− MEFs with cDNA encoding either Xbp1u pre-mRNA (which can be processed by IRE1α; Figure 3B, middle) or Xbp1s mRNA (Figure 3B, right) restored caspase 3 cleavage upon C12 treatment in a large number of cells. In contrast, transfection of Ire1α−/− MEFs with Xbp1s cDNA (Figure 3C right), but not Xbp1u cDNA (which is present endogenously but remains unspliced, Figure 3C, middle), restored caspase-3 cleavage upon C12 treatment. In control experiments, C12-treatment of Xbp1−/− MEFs transfected with an empty plasmid was not associated with caspase 3-cleavage, verifying that transfection of this cell type was not responsible for caspase activation (Figure S1F). Taken together, these experiments indicate that expression of XBP1s in XBP1s-deficient MEFs (Xbp1−/− or Ire1α−/− MEFs) is sufficient to re-establish C12-mediated caspase cleavage.

thumbnail

Figure 3. Transient expression of XBP1s restores caspase 3 cleavage in Xbp1−/− and Ire1α−/− MEFs.

A. Caspase activation in C12-treated wt MEFs assessed by cleaved caspase 3 immunocytochemistry. Images are shown in the absence (top) and presence (bottom) of C12 (25 µM, 2 hours) with DAPI (magenta) and cleaved caspase 3 (red) staining. B. Cleaved caspase 3 immunostaining in C12-treated Xbp1−/− cells. Untransfected cells (left panels) show limited cleaved caspase 3 immunostaining in the presence of C12 although transient expression of cDNA encoding XBP1u (middle panels) or XBP1s (right panels) restores caspase 3 cleavage upon C12 treatment. C. Cleaved caspase 3 immunostaining in C12-treated Ire1α−/− cells. Untransfected cells (left panels) and cells transfected with cDNA encoding XBP1u (middle panels) show limited cleaved caspase 3 immunostaining in the presence of C12 although expression of cDNA encoding XBP1s (right panels) restores caspase 3 cleavage upon C12 treatment. D. Number of cells showing cleaved caspase 3 immunostaining after C12 treatments. Data is shown for wt MEFs (white bars) and Xbp1−/− and Ire1α−/− MEFs transiently transfected with cDNA encoding XBP1u (black) or XBP1s (grey) in the presence and absence of C12 (25 µM, 2 hours). Scale bar in panel A refers to all images.

doi:10.1371/journal.ppat.1003576.g003

C12-mediated apoptosis does not require XBP1s transcriptional activity

XBP1s is a member of the cAMP response element-binding protein (CREB)/ATF basic region–leucine zipper family of transcription factors and, consistent with this function, XBP1s is modular containing a polybasic region, a leucine zipper motif and a transcriptional activation domain [36] (Figure 4B). Therefore, experiments were conducted to investigate whether XBP1s transcriptional activity was required for C12-mediated apoptosis. Treatment of wt MEFs with inhibitors of transcription (actinomycin) or translation (cycloheximide) during C12 stimulation did not prevent caspase activation (Figure 4A). As such, in response to C12-stimulation, neither acute activation of XBP1s transcriptional activity nor acute protein synthesis of an XBP1s-dependent transcript are responsible for C12-induced apoptosis.

thumbnail

Figure 4. Leucine zipper and transcriptional activation domains of XBP1s are sufficient for C12-mediated caspase activation.

A. Acute inhibition of RNA or protein synthesis with actinomycin (actin.) or cycloheximide (cyclo.) does not inhibit C12-induced caspase activation in wt MEFs. B. Domain structure of XBP1s and XBP1s truncations. XBP1s contains a polybasic domain (grey), leucine zipper domain (black) and transcriptional activation domain (blue). The location of the splice site that converts XBP1u pre-mRNA to XBP1s mRNA is also shown (red). The FLAG-tag on all constructs is located at the amino-terminus. C. Analysis of cellular localization of XBP1s and XBP1s truncations by immunocytochemistry. Panels are shown for anti-FLAG immunostaining (top), DAPI staining (middle), and merged images (bottom). D. Expression of XBP1s truncations that contain the leucine zipper and transcriptional activation domains (XBP1Δ1 and XBP1Δ2) is sufficient to restore C12-mediated caspase activation in Ire1α−/− (top panels) and Xbp1−/− (bottom panels) MEFs. Expression of XBP1N failed to restore C12-mediated caspase activation. Images are shown for DAPI staining (magenta) and caspase immunostaining (red) in the absence and presence of C12. E. XBP1s truncations that restore C12-mediated caspase activation (XBP1Δ1 and XBP1Δ2) are transcriptionally inactive. Normalized XBP1s transcriptional activity was measured in wt MEFs using an XBP1s-responsive luciferase-based reporter and co-expression of control plasmid, XBP1s, or XBP1 truncations. Individual scale bars are shown for panels C and D.

doi:10.1371/journal.ppat.1003576.g004

To gain insight into the role of XBP1s domains in C12-mediated apoptosis, a series of XBP1s truncation constructs were generated (Figure 4B). In wt MEFs, XBP1s is predominantly localized to the nucleus, although in agreement with prior biochemical analysis, low levels of XBP1s could also be detected in the cytoplasm [36] (Figure 4C and Figure S2B). Deletion of the amino terminus and polybasic region from XBP1s produced a truncation construct (XBP1Δ1) that was distributed throughout the cell (Figure 4B and 4C). When expressed in Ire1α−/− or Xbp1−/− MEFs, XBP1Δ1 was able to re-establish caspase 3 cleavage upon C12 treatment (Figure 4D, left). In a similar manner, an XBP1s truncation construct that consisted of only the leucine zipper and transcriptional activation domains (XBP1Δ2) was distributed throughout the cell (Figure 4B and 4C) and restored caspase 3 cleavage in C12-stimulated Ire1α−/− and Xbp1−/− MEFs (Figure 4D, middle). A truncation construct encompassing the amino-terminal domains of XBP1s (XBP1N, Figure 4B) failed to re-establish caspase 3 cleavage in C12 stimulated Ire1α−/− or Xbp1−/− MEFs (Figure 4D, right). As such, consideration of C12-mediated caspase 3-cleavage in XBP1s-deficient MEFs expressing XBP1Δ2 or XBP1N suggested that the transcriptional activation domain of XBP1s contains a protein sequence that is responsible for C12-mediated caspase activation. However, instability of additional XBP1s truncation constructs that were generated precluded further analysis to identify a minimal XBP1s region that is necessary for C12-mediated caspase 3-cleavage. For instance, truncation constructs such as those that encode the XBP1s transcriptional activation domain and carboxy-terminus or the XBP1s transcriptional activation domain alone could not be detected by immunocytochemistry or western blot analysis (Figure S2C and data not shown). As such, our analysis indicates that the leucine zipper and transcriptional activation domains of XBP1s (XBP1Δ2) constitute a minimal XBP1s region that can be stably expressed and is sufficient for caspase activation in C12-treated Ire1α−/− or Xbp1−/− MEFs.

Next, experiments were performed to assess the ability of XBP1s truncation constructs to mediate transcriptional activity. In these assays, wt MEFs were co-transfected with an XBP1s-responsive luciferase reporter and either XBP1s or an XBP1s truncation construct [43], [44]. As expected, robust transcriptional responses were observed when XBP1s was co-expressed with the reporter (Figure 4E). In contrast, XBP1N, which lacks a transcriptional activation domain, was not associated with transcriptional activity (Figure 4E). The XBP1Δ1 and XBP1Δ2 truncation constructs that restore caspase 3-cleavage in C12-treated Ire1α−/− and Xbp1−/− MEFs were also not associated with XBP1s-dependent transcriptional activity (Figure 4E and Figure S2A). Taken together, these studies indicate that: (i) the leucine zipper and transcriptional activation domains of XBP1s (XBP1Δ2) constitute a minimal, stable XBP1s fragment that restores caspase activation upon C12 stimulation in XBP1s-deficient cells and; (ii) C12-mediated apoptosis does not require XBP1s-transcriptional activity.

XBP1s regulates a common mechanism for acyl homoserine lactone-mediated caspase activation

Acyl homoserine lactones are a common chemical scaffold used by diverse bacterial species for QS [12]. Therefore, experiments were performed to investigate if XBP1s-dependent mechanisms mediate cellular responses to N-(3-oxo-tetradecanoyl) homoserine lactone (C14, Figure 5A), a QS molecule generated by the gram-negative, pathogenic bacteria Yersinia enterolitica and Burkholderia pseudomallei. Treatment of wt MEFs with C14 produced significant cell death, as assessed by calcein AM fluorescence (Figure 5B, left), and activation of executioner caspases (Figure 5C, right). In contrast, Ire1α−/− MEFs were largely resistant to C14-mediated cytotoxicity (Figure 5B, right) and demonstrated significantly reduced caspase activation (~20%) relative to wt cells (Figure 5C, right). As expected from direct measurements of caspase activity, robust cleavage of caspase 3 could be detected in C14-treated wt MEFs; however, cleaved caspase 3 immunostaining was largely absent in Ire1α−/− MEFs (Figure 5D). Transfection of Ire1α−/− MEF cells to express either XBP1s or XBP1Δ2 restored caspase 3-cleavage in C14 treated cells (Figure 5D), as observed in C12-treated cells.

thumbnail

Figure 5. XBP1s mediates cellular responses to the C14 homoserine lactone and in different cell types.

A. Structure of N-(3-oxo-tetradecanoyl) homoserine lactone (C14). B. Ire1α−/− MEFs are protected from C14-mediate cell death as assessed by calcein AM staining. C. Normalized caspase 3/7 activity in wt (black) and Ire1α−/− (grey) MEFs in control conditions and after treatment with C12 or C14 (25 µM, 4 h). D. Caspase activation in C14-treated MEFs assessed by cleaved caspase 3 immunocytochemistry. Images are shown in the absence (top) and presence (bottom) of C14 (25 µM, 2 hours) with DAPI (magenta) and cleaved caspase 3 staining (red). Wildtype MEFs (first panels) and Ire1α−/− MEFs that are either untransfected (second panels) or transfected to express XBP1s (third panels) or XBP1Δ2 (fourth panels) are shown. E. Over-expression of XBP1Δ2 enhances executioner caspase activation when heterologously expressed in FRT cells. (left) Fluorescence images of cell enriched for expression of XBP1Δ2 (FRT-XBP1Δ2), anti-FLAG immunostaining (top), DAPI fluorescence (middle) and a merged image (bottom) are shown. (right) Caspase 3/7 activation is enhanced in FRT-XBP1Δ2 cells (grey bars) relative to control cells (black bars), by C12 (25 µM) at 2 and 4 hours and by C14 (25 µM) at 4 hours. F. Over-expression of XBP1Δ2 enhances C12- and C14- (25 µM) mediated caspase 3/7 activation when heterologously expressed in Hela cells. Statistical analysis was by t-test and for pairwise comparison of control and XBP1Δ2 overexpressing cells, * p<0.001 and ** p<0.0001.

doi:10.1371/journal.ppat.1003576.g005

Studies were also performed to investigate whether XBP1Δ2 affects cytotoxic response to acyl homoserine lactones in other cell types. A Fisher rat thyroid (FRT) cell line was generated that was highly enriched for expression of XBP1Δ2 (FRT-XBP1Δ2, Figure 5E, left). Treatment of FRT-XBP1Δ2 with C12 or C14 resulted in increased activation of executioner caspases relative to control cells (FRTcon, Figure 5E, right). Similarly, enhanced caspase activation was observed in a Hela cell line enriched for XBP1Δ2 expression upon treatment with C12 or C14 (Figure 5F). It is noteworthy that in all cell types studied C14 produced higher levels of caspase activation than C12. Studies with further acyl homoserine lactones indicated that acyl chains of >12 carbon atoms and substitution at the third carbon of the acyl chain are required for toxicity (Figure S3). Taken together, these experiments indicate that: (i) the leucine zipper and transcriptional activation domains (XBP1Δ2) of XBP1s regulate activation of caspases in response to different homoserine lactones and, (ii) XBP1Δ2 results in increased caspase activation in the presence of endogenous XBP1s.

C12 activates alternative cellular responses via XBP1s-independent mechanisms

C12 activates multiple stress response signalling pathways in host cells [14], [17]. The observation that Ire1α−/− and Xbp1−/− MEFs are protected from C12-induced cell death afforded the opportunity to investigate whether distinct cellular signalling responses are associated with or unrelated to C12 cytotoxicity. Phosphorylation of eIF2α and p38 MAPK have previously been reported in primary macrophages, fibroblasts and epithelial cells [17]. In agreement with this study, increased phospho-eIF2α (p-eIF2α; ~2.5-fold change) and phospho-p38 MAPK (p-p38 MAPK; ~2.5-fold change) could also be detected in wt MEFs after C12 exposure for 45 minutes (Figure 6A, top panels). A similar pattern of phosphorylation of eIF2α and p38 MAPK was observed in C12-treated Ire1α−/− and Xbp1−/− MEFs (Figure 6A, middle and bottom panels; ~2.5 and ~3-fold increases in p-eIF2α, and ~2.5 and ~3.5-fold increases in p-p38 MAPK); indicating that these responses are independent of XBP1s and IRE1α activity. As both Ire1α−/− and Xbp1−/− MEFs are resistant to C12 cytotoxicity, these studies also suggest that phosphorylation of p-eIF2α and p-p38 MAPK does not contribute greatly to C12-mediated cell death in MEFs. Consistent with this notion, inhibition of p38 MAPK activity (using SB203580 or SB202190) did not inhibit C12 cytotoxicity or caspase 3/7 activation in wt MEFs (data not shown).

thumbnail

Figure 6. XBP1-independent cellular responses to C12.

A. Immunoblot analysis of phosphorylated eIF2α (p-eIF2α, left) and phosphorylated p38 (p-p38, right) levels in wt, Ire1α−/− and Xbp1−/− MEFs. Cells were treated with 25 µM C12 for 45 minutes. B. (top) C12 treatment (25 µM, 45 min) of Perk−/− MEFs results in phosphorylation of eIF2α (bottom) Control experiments confirm that ER stress (brefeldin A (BFA), 2 hours) in wt MEFs, but not Perk−/− MEFs, produces p-eIF2α. C. C12 treatment increases c-Jun levels in wt MEFs but not in Ire1α−/−, and Xbp1−/− MEFs. Cells were treated with 25 µM C12 for 90 minutes (bottom) and c-Jun levels were characterized by image analysis of immunostained cells (green). Images of DAPI staining are also shown (magenta). D. Quantitative analysis of normalized c-Jun levels in wt, Ire1α−/−, and Xbp1−/− MEFs. Scale bar in panel C refers to all images.

doi:10.1371/journal.ppat.1003576.g006

PERK phosphorylates eIF2α during periods of ER stress [32]; therefore, experiments were performed to investigate whether PERK is activated by C12. Phosphorylation of eIF2α was, however, preserved in C12-treated Perk−/− MEFs (Figure 6B, top; ~3-fold increase). As expected, control experiments confirmed that ER stress induced by brefeldin A (BFA) produced p-eIF2α in wt MEFs (~4-fold increase) but not Perk−/− MEFs (~0.9-fold change) (Figure 6B, middle and bottom). Together, these studies indicate that C12 challenge activates alternative kinase(s) activity to generate p-eIF2α; however, they do not formally demonstrate that PERK does not contribute to eIF2α phosphorylation.

Levels of c-jun mRNA have also been reported to increase in C12-treated primary macrophages, fibroblasts and epithelial cells [17]. In wt MEFs, c-Jun protein levels increased by approximately two-fold after 90 minutes treatment with 25 µM C12 (Figure 6C, left, and Figure 6D). In contrast, c-Jun protein levels were not altered by C12 in Ire1α−/− or Xbp1−/− MEFs (Figure 6C, middle and right, and Figure 6D). At present, these studies cannot distinguish whether c-Jun levels increase in wt MEFs in an XBP1s (or IRE1α) -dependent manner or due to C12-mediated cytotoxicity; however, these studies confirm that C12 cytotoxicity is associated with increased c-Jun levels. It is noteworthy that in unstimulated conditions, c-Jun levels in wt and knockout MEFs varied by approximately three-fold; as such, elevated levels of c-Jun, at least in the absence of XBP1s, are not sufficient to mediate C12 cytotoxicity. These studies indicate that C12-mediated host cell responses occur via both XBP1s-dependent and -independent mechanisms and C12-mediated production of p-eIF2α and p-p38 MAPK in MEFs does not contribute greatly to cell death.

Discussion

Infections associated with P. aeruginosa result in significant mortality and constitute a major worldwide healthcare burden. Our understanding of P. aeruginosa virulence mechanisms is limited and there is an urgent need to identify new approaches that can be employed to reduce P. aeruginosa infectivity. P. aeruginosa employ QS to regulate growth, virulence factor expression and biofilm formation. In addition to quorum signalling, P. aeruginosa-derived C12 homoserine lactone activates several host cell responses including cytotoxicity. The major conclusion of this study is that C12-mediated host cell cytotoxic responses largely require expression of the XBP1s transcription factor (Figure 7). Cell death and caspase activation were dramatically reduced (~95%) in cells that cannot generate XBP1s (Ire1α−/− MEFs) or lack the XBP1 gene (Xbp1−/− MEFs). To the best of our knowledge, this study represents the first description of cells that are C12-tolerant due to genetic ablation of a protein. Restoring XBP1s expression in either Ire1α−/− or Xbp1−/− MEFs was sufficient to re-establish caspase 3 cleavage upon C12 stimulation. Although the present study does not provide full mechanistic detail, we demonstrate that a fragment of XBP1s encompassing the leucine zipper and transcriptional activation domains (XBP1Δ2) that is not transcriptionally active is sufficient to restore C12-mediated caspase 3 cleavage. Knockout cell lines were used to incisively demonstrate the role of XBP1s in homoserine lactone-mediated cell death; however, expression of XBP1Δ2 in rat and human epithelial cells resulted in enhanced caspase activation in response to C12- and C14-stimulation, indicating that XBP1s can mediate apoptotic responses in distinct cell types. Further experiments will be required to establish that XBP1s regulates C12-mediated apoptosis in cells that are exposed to P. aeruginosa, including macrophages, neutrophils and airway epithelial cells; however, XBP1s is expressed at high levels in these cells [45].

thumbnail

Figure 7. Role of XBP1s in C12-mediated cellular responses.

Activation of caspases is dependent upon XBP1s, albeit by a mechanism that does not involve transcription. Phosphorylation of p38 MAPK and eIF2α is XBP1s-independent. Stimulation of cells with C12 does not activate IRE1α and presumably does not activate other ER stress response pathways. No inferences about c-Jun synthesis can be drawn from the current study.

doi:10.1371/journal.ppat.1003576.g007

The concentration of C12 observed in liquid cultures is ~5 µM and biofilms may generate up to ~600 µM C12 [21], [34]. Caspase activation and the appearance of characteristic apoptotic morphology were observed in wt MEFs that were treated with 5 µM C12. Cellular responses, including phosphorylation of p38 MAPK and eIF2α were reported in cells exposed to 5–10 µM C12 [17]. In vivo studies indicate that low concentrations of C12 (1–10 µM) produce profound responses [46]. Furthermore, it has been proposed that host cells may be exposed to high local C12 concentrations generated by P. aeruginosa structures including micro-colonies and biofilms [47], [48]. The only rigorous validated C12 receptor is T2R38, this bitter taste receptor is activated by C12 to stimulate host antimicrobial responses including nitric oxide synthesis and mucociliary clearance [26]. In human subjects, common loss-of-function polymorphism in T2R38 were linked to host susceptibility to sinonasal gram-negative bacterial infections, suggesting that T2R38 is a key determinant of upper airway innate defense mechanisms [26]. In primary cell cultures, TR238-mediated antimicrobial responses were stimulated by C12 in the concentration range 10–100 µM. As such, we predict that C12 concentrations considered in these studies will be clinically relevant. Formal verification that C12-mediated cytotoxicity enhances P. aeruginosa virulence will require identification of pharmacological tools that can be used to block caspase activation in vivo.

XBP1s is a member of the CREB/ATF basic region-leucine zipper family of transcription factors and performs pleiotropic transcriptional functions. Approaches including expression profiling and chromatin immunoprecipitation have revealed that XBP1s regulates gene expression for both constitutive and inducible arms of ER stress response pathways; however, XBP1s-responsive promoter regions also regulate expression of genes involved in signal transduction, redox homeostasis, cell growth and differentiation and carbohydrate metabolism [35], [44], [49]. Studies in knock-out mice have revealed that XBP1s is essential for hepatogenesis, B lymphocytes differentiation, cardiac myogenesis and development of exocrine tissue [50], [51], [52], [53]. Targeted deletion of XBP1s in murine intestinal epithelial cells results in enhanced inflammatory responses and Xbp1 polymorphisms are associated with Crohn's disease and ulcerative colitis [54]. In C. elegans, P. aeruginosa-mediated PMK-1 p38 MAPK activation during development induces ER stress that is lethal in the absence of XBP1s [55]. In general, these studies indicate that XBP1s typically acts in a protective manner to restore cellular homeostasis when protein load on the ER is excessive [35]. XBP1s function has, however, been linked to cell death and over long time courses (days) increased levels of XBP1s have been associated with apoptosis in endothelial and pancreatic β cells [56], [57]. The current study represents the first descriptions of an unconventional (non-transcriptional) role for XBP1s and of a function for XBP1s in regulating acute apoptosis.

Additional insights into the role of cell stress response pathways in C12 stimulated cells are afforded by the present study (summarized in Figure 7). Activation of ER stress response pathways has been proposed as a mechanism by which C12 initiates host cell responses [14], [48]. Direct assessment of IRE1α splicing activity and pharmacological inhibition of apoptotic pathways that are initiated by IRE1α suggests that C12 does not activate IRE1α. An additional inference that can be drawn from these observations is that ‘house-keeping’ levels of XBP1s are sufficient to mediate apoptotic responses to C12. However, it is noteworthy that immune responses initiated by P. aeruginosa (via TLR4 and TLR5) will result in IRE1α-activation and increased levels of XBP1s [58]. ER stress-induced PERK activation has also been proposed to be responsible for C12-mediated eIF2α phosphorylation; however, robust eIF2α phosphorylation was observed in Perk−/− MEFs suggesting that an alternative kinase(s) catalyzes this response. Although the present studies do not formally rule out PERK-mediated eIF2α phosphorylation, this scenario seems unlikely given that: (i) C12-mediated IRE1α ER stress responses are negligible, (ii) PERK and IRE1α sense ER stress by a similar mechanism [59] and, (iii) deletion of PERK does not alter cytotoxic responses to C12. In response to cell stress, eIF2α is also phosphorylated by eIF2α kinase 1 (the heme-regulated inhibitor kinase), eIF2α kinase 2 (protein kinase RNA-activated, PKR) or eIF2α kinase 4 (GCN2) [60]; further work will be required to establish which eIF2α kinase(s) responds to C12. The role of individual stress response pathways to overall C12-mediated cytotoxicity is not well understood. The observations that p38 MAPK phosphorylation is conserved in Ire1α−/− and Xbp1−/− MEFs and that pharmacological inhibition of p38 MAPK does not prevent C12-mediated apoptosis suggest that this pathway is of limited importance to C12-mediated cell death. Similarly, eIF2α phosphorylation is preserved in Ire1α−/− and Xbp1−/− MEFs also suggesting that this cellular response has little relevance to C12-mediated apoptosis. Finally, it is noteworthy that caspases are activated in Ire1α−/− and Xbp1−/− MEFs in response to C12-stimulation, albeit at dramatically reduced levels (~5%) relative to wt MEFs. As such, our study indicates that XBP1s-dependent and -independent processes that contribute to caspase activation are initiated in C12-stimulated cells, but that XBP1s-dependent mechanisms are dominant.

How might XBP1s contribute to cell death in C12-stimulated cells? Our study formally verifies that caspase activation mediates apoptotic cell death in MEFs. Executioner caspase activity was ostensibly used as a metric of cell death; however, caspase 8 was also activated in C12-stimulated MEFs (data not shown) as previously reported in other cell types [16], [18]. Caspase 8 activation typically indicates that extrinsic apoptotic pathways initiated by cell surface receptors are operating [29]. As such, we speculate that XBP1s promotes initiation of extrinsic apoptotic responses through formation of the death-inducing signalling complex in a C12-dependent manner. Precedents of leucine zipper-containing proteins causing intrinsic and extrinsic apoptosis have been reported. Similar to XBP1s, the prostrate apoptosis response-4 protein (Par-4) contains a leucine zipper motif and nuclear localization sequences. Depending upon cell type, Par-4 has been demonstrated to either sensitize cellular responses to apoptotic stimuli or to directly activate apoptosis; however, the mechanism of these responses is not fully elucidated [61]. Further studies will be required to test the hypothesis that XBP1s mediates activation of extrinsic apoptotic responses in a C12-dependent fashion.

In summary, the present study identifies XBP1s as a key determinant of apoptotic responses initiated by QS molecule generated by Pseudomonas aeruginosa, Yersinia enterolitica and Burkholderia pseudomallei. The leucine zipper and transcriptional activation domains of XBP1 are sufficient to mediate apoptotic responses; however, XBP1s transcriptional activity is not required for cell death. These studies advance our understanding of host responses to C12 and should facilitate rational design of approaches to investigate whether C12-mediated host cell apoptosis is pathologically relevant.

Materials and Methods

Cell lines and cell culture

Immortalized wt and knockout MEF cell lines used in this study were previously described and RT-PCR analysis of these cells was performed using published primer sequences [32], [33], [37], [39]. MEFs were cultured in DMEM H21 supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and nonessential amino acids. Fischer rat thyroid (FRT) epithelial cells were obtained from the UCSF cell culture facility and cultured in Ham's F12 supplemented as for MEFs. Hela cells were obtained from the UCSF cell culture facility and cultured in DMEM H21 supplemented as for MEFs. MEF and FRT cells were transfected using jetPRIME (Polyplus Transfection) and Hela cells were transfected with Lipofectamine LTX with Plus reagent (Life Technologies).

Reagents and chemicals

Homoserine lactones (including C12 (N-(3-oxododecanoyl)-l-homoserine lactone) and C14 (N-(3-oxodotetradecanoyl)-l-homoserine lactone)) were obtained from Sigma. For some experiments, C12 was prepared using a previously described synthetic route [62]. Structure and purity (>99%) of synthesized C12 were confirmed by proton NMR, and caspase activation in wt or Xbp1−/− MEFs was similar in response to synthesized or purchased C12. Details of homoserine lactone dosing is provided in Figure Legends or text. Calcein acetoxymethyl ester (AM), DAPI and thapsigargin was obtained from Life Technologies and used as directed by the manufacturer. Pharmacological modulators were purchased from various sources (as detailed below) and cells were typically pre-treated with compounds for 30 minutes, at concentrations given in parenthesis, prior to homoserine lactone challenge or other experimental maneuvers. Cycloheximide (5 µg/ml) and CA-074-Me (10 µM) were obtained from Calbiochem. STF-080310 (50 µM) was obtained from Tocris. Z-VAD-fmk (10 µM) was obtained from Promega. SB203580 (10 µM), SB202190 (10 µM), SP600125 (10 µM), ALLN (10 µM), brefeldin A (1.25 µg/ml) and actinomycin (1 µg/ml) were obtained from Santa Cruz Biotechnology.

Antibodies, western blotting and immunocytochemistry

Antibodies against, IRE1α, PERK, cleaved and full length caspase 3 and 7, p-eIF2α, p-p38 MAPK and c-Jun were obtained from Cell Signalling. Antibody against XBP1 was purchased from Santa Cruz. Antibody against FLAG-tag was obtained from Sigma. Western blotting was performed using standard procedures with chemiluminescence detection. Immunocytochemistry was performed on fixed and permeabilized cells using indirect immunodetection with appropriate fluorophore-conjugated secondary antibodies and DAPI as a counterstain. Imaging was performed using a Nikon Eclipse TE2000U inverted microscope equipped with an Exfo X-Cite light source, Hamamatsu EM-CCD deep-cooled camera and appropriate filter cubes and objectives (Nikon S Fluor 20× N.A. 0.75 or Plan Fluor 40× N.A. 0.75). For quantitative immunodetection, cell from different experiments were labelled in parallel, imaged with identical microscope settings and analyzed using Fiji image processing software.

Apoptosis assays and cell density analysis

Caspase activity was measured using Caspase-Glo homogeneous luminescent assays (Promega). In different experiments, caspase activation in C12-treated wt MEFs varied by ~50% for undetermined reasons. As such, control experiments were always performed and are presented, such that control data and experimental maneuvers can be directly compared. Normalized caspase activation data is presented as mean ± S.D. for an individual experiment (comprised of 6–12 individual measurements), and is representative of at least duplicate experiments. To characterize cell density, cells were labelled with calcein-AM and imaged using a Nikon Eclipse TE2000U inverted microscope (described above) equipped with a Nikon Plan Fluor 10×/NA 0.3 objective. Relative cell number was calculated from background-corrected, integrated fluorescence areas and cell density was derived by comparison of relative cell number before and after an experimental maneuver. Data is presented as mean ± S.E. and was derived from 3–5 independent experiments in which 3–6 cell areas were imaged per experiment.

Plasmids, molecular biology and luciferase-based reporter assays

Plasmids containing FLAG-tagged murine XBP1u and XBP1s cDNA were obtained from Addgene (plasmids 21832 and 21833; [63]). For experiments, the coding regions for XBP1u and XBP1s were excised as HindIII/XbaI fragments, subcloned into pcDNA3.1/Hygro, and an oligo duplex was used to regenerate the FLAG-tag (amino acid sequence MDYKDDDDL). Carboxy-terminal FLAG-XBP1s truncations (Figure 4B) were generated by pcr as HindIII/XbaI-tagged amplicons that were subcloned into pcDNA3.1/Hygro containing an in-frame FLAG-tag. The amino-terminal FLAG-XBP1s truncation (Figure 4B) was generated by pcr as a BglII/EcoRI-tagged amplicon that was subcloned into the BamHI/EcoRI sites of pcDNA3.1; for experiments, FLAG-tagged XBP1 amino terminus was subsequently subcloned into pcDNA3.1/Hygro as an NheI/XbaI fragment. Domain boundaries for truncations were based on those previously reported for human XBP1s [36]. For FLAG-XBP1s, the polybasic, leucine zipper (which contains amino acids involved in transcription factor dimerization) and transcriptional activation domains start at Arg76, Ala94 and Ala168, the transcriptional activation domain ends at Val283 and the amino terminal domain ends at Iso197 (corresponding to residues Arg68, Ala86, Ala160, Val275 and Iso189 of untagged XBP1s). Sequence analysis was used to confirm all constructs generated in this study. For experiments in MEFs that assessed the role of full length and truncated XBP1 regions in caspase activation, pcDNA3.1/Hygro was used as a control (empty) vector. Cell lines enriched for expression of an XBP1s deletion construct (XBP1Δ2, Figure 4B) were generated by repeated culture of transfected cells in 300 µg/ml hygromycin; cells transfected with pcDNA3.1/Hygro and selected in 300 µg/ml hygromycin (FRTcon and Helacon) were used as a control.

A luciferase-based reporter of IRE1α activity was generously provided by Albert Koong (Stanford University). Briefly, this reporter (termed XBP1-luc) consists of cDNA encoding the first 208 amino acids of human Xbp1, including a 26-nucleotide splice site that is recognized by IRE1α, fused to firefly luciferase [41]. A plasmid-based vector was generated for the current studies by subcloning reporter cDNA (provided in the pLPCX retroviral vector, Clontech) into pcDNA3.1/Hygro as a HindIII/NotI fragment. Assays of IRE1α splicing activity were performed in transiently transfected wt MEFs or in an FRT cell population enriched for expression of the reporter construct by repeated culture of cells in 300 µg/ml hygromycin. A luciferase based reporter of XBP1s activity was purchased (pGL4[lu2P/ATF6-RE/Hygro] (Promega)); this reporter contains five direct repeats of the sequence 5′-ATCGAGACAGGTGCTGACGTGGCATTC-3′ and is similar to a previously described XBP1s-responsive reporter (UPRE/5×ATF6GL3) [43], [44]. Assays of XBP1 transcriptional activity were performed in MEFs transiently transfected with plasmids expressing full length or truncated XBP1s (or pcDNA3.1/Hygro as a control) and pGL4[lu2P/ATF6-RE/Hygro] at a ratio of 9:1. Luciferase-based reporter assays were performed using the Bright-Glo Assay system as directed by the manufacturer (Promega).

Supporting Information

Figure S1.

A. Cell density assessment using calcein AM labelling and fluorescence microscopy. (column 1) Representative image of control cells. (column 2) Inhibition of proteolytic enzymes by CA-074-Me (10 µM) and ALLN (10 µM) does not prevent C12-mediated cell death (25 µM, 4 h), confirming that z-FAD-fmk inhibits caspases (see also Figure 1). (column 3) CA-074-Me and ALLN are not associated with toxicity over the time course of experiments. (column 4) Treatment of cells with C12 (25 µM) or thapsigargin (250 nM) for 2 hours produces limited cell loss (see also Figure 2C). B. Calcein AM labelling of wt MEFs treated with low concentrations of C12 for 4 hours. Examples of cells with clear apoptotic morphology are highlighted with arrowheads (see also Figure 1E). C. Inhibition of JNK does not inhibit caspase activation (see also Figure 2A). D. (left) Relative IRE1α activity in FRT cells measured using XBP1-luc (see also Figure 2C). Cells were treated with the ER stress inducing agents tunicamycin (tun, 0.5 µg/ml) and thapsigargin (thaps, 250 nM) or C12 (25 µM) for 4 hours. (right) Normalized caspase 3/7 activation in FRT cells treated as in IRE1α activity measurements. C12 did not significantly increase IRE1α activity relative to control levels although C12-stimulation resulted in robust caspase 3/7 activation. ER stress inducing agents did not induce caspase 3/7 activation over the duration of experiments. Statistical analysis was by ANOVA with Dunnett post hoc test using untreated cells as the control condition; ** p<0.0001. E. Western blot of (uncleaved) caspase 3 and caspase 7 in wt, Ire1α−/− and Xbp1−/− MEFs. F. Transfection of Xbp1−/− MEFs with a control (empty) plasmids did not result in caspase 3 cleavage upon C12 treatment (25 µM, 2 h). Staining is shown for DAPI (left) and cleaved caspase 3 (right) (see also Figure 3).

doi:10.1371/journal.ppat.1003576.s001

(TIF)

Figure S2.

A. Measurement of XBP1s-mediated transcriptional activity in wt, Ire1α−/− and Xbp1−/− MEFs (see also Figure 4E). In all cell types, Xbp1s co-transfection with the XBP1s-responsive reporter construct produced robust transcriptional activity. Co-transfection of wt and Xbp1−/− MEFs with Xbp1u cDNA produced limited transcriptional activity, consistent with the ability of these cells to process Xbp1u pre-mRNA and generate XBP1s via IRE1α activity (as expected, intrinsic activity of IRE1α is limited such that XBP1s-transcriptional activity in Xbp1u transfected cells is lower than that in Xbp1s transfected cells). In contrast, Ire1α−/− MEFs were unable to process Xbp1u cDNA such that no transcriptional activity was reported. No transcriptional activity was reported in any cell type for co-transfection with plasmids encoding XBP1N and XBPΔ2. Statistical analysis was by ANOVA with Dunnett post hoc test; * p<0.05 and ** p<0.0001 versus control data. (inset) Anti-FLAG-tag western blot of wt MEFs expressing XBP1s truncation constructs to confirm appropriate expression. B. Immunostaining of FLAG-XBP1s transfected wt MEFs. Camera sensitivity was adjusted such that low levels of XBP1s could be detected in the cytoplasm of certain transfected cells (see also Figure 4C). C. Schematic representation of XBP1s truncation constructs that were generated, confirmed by sequence analysis and failed to express in wt MEFs. XBP1s contains a polybasic domain (grey), leucine zipper domain (black; which consists of the amino acids involved in transcription factor dimerization) and transcriptional activation domain (blue). The location of the splice site that converts XBP1u pre-mRNA to XBP1s mRNA is also shown (red). Leu-to-ala mutants of XBP1s and XBPΔ2 contained alanine residues in place of leucine residues at all seven positions in the leucine zipper motif and were generated using gBlocks Gene Fragments (Integrated DNA Technologies).

doi:10.1371/journal.ppat.1003576.s002

(TIF)

Figure S3.

A. Structures of acyl homoserine lactones used in these studies: C6 (N-(ß-Ketocaproyl)-l-homoserine lactone); C10 (N-(3-Oxodecanoyl)-l-homoserine lactone); C12; C14; C14-b (N-Tetradecanoyl-dl-homoserine lactone); C14-OH (N-(3-Hydroxytetradecanoyl)-dl-homoserine lactone). Carbons at position 1 and 3 are highlighted in red (top). B. Representative images of calcein AM labelled wt MEFs treated with acyl homoserine lactones (4 h, 25 µM or 50 µM of racemic mixtures; see also Figs. 1 and 5). C. Caspase 3/7 activation in wt (left) and Ire1α−/− (right) MEFs after treatment with acyl homoserine lactones (4 h, 25 µM or 50 µM of racemic mixtures). No activation of caspases was observed when acyl chains were <12 carbon atoms in length. Substitutions at carbons one and three are required for caspase activation and 3-oxo- substitutions produce significantly greater activation of caspases than 3-hydroyx- substitutions. Ire1α−/− MEFs are protected from C12, C14 and C14-OH caspase activation relative to wt MEFs.

doi:10.1371/journal.ppat.1003576.s003

(TIF)

Acknowledgments

The authors thank Drs Alan S. Verkman, Alex J. Smith, Francis Szoka, Joanne Engel, John-Paul Upton (UCSF), Jonathon Koff (Yale), and Albert Koong (Stanford) for helpful discussion and/or provision of reagents that facilitated this project. The authors are particularly grateful to Scott A. Oakes (UCSF) for support, discussion and reagents provided throughout this project.

Author Contributions

Conceived and designed the experiments: PMH. Performed the experiments: CDV MOA PMH. Analyzed the data: CDV PMH. Contributed reagents/materials/analysis tools: CDV MOA FRP PMH. Wrote the paper: PMH.

References

  1. 1. Gaynes R, Edwards JR (2005) National Nosocomial Infections Surveillance System (2005) Overview of Nosocomial infections caused by Gram-negative Bacilli. Clin Infect Dis 15: 389–391. doi: 10.1086/432803
  2. 2. Craven DE (2006) What is healthcare-associated pneumonia, and how should it be treated? Curr Opin Infect Dis 19: 153–160.
  3. 3. Jones RN (2010) Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 51: S81–S87. doi: 10.1086/653053
  4. 4. Fujitani S, Sun H-Y, Yu VL, Weingarten JA (2011) Pneumonia due to Pseudomonas aeruginosa, Part I. Chest 139: 909–919. doi: 10.1378/chest.10-0166
  5. 5. Murray TS, Egan M, Kazmierczak BI (2007) Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr 19: 83–88. doi: 10.1097/mop.0b013e3280123a5d
  6. 6. Bilton D (2008) Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 14: 595–599. doi: 10.1097/mcp.0b013e328312ed8c
  7. 7. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, et al. (2010) A persistent and diverse microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 14: 9–59. doi: 10.1089/omi.2009.0100
  8. 8. Giamarellou H, Kanellakopoulou K (2008) Current therapies for Pseudomonas aeruginosa. Crit Care Clin 24: 261–278. doi: 10.1016/j.ccc.2007.12.004
  9. 9. Flemming HC, Wingender J (2010) The biofilm matrix. Nat Rev Microbiol 8: 623–633. doi: 10.1038/nrmicro2415
  10. 10. Ho J, Tambyah PA, Paterson DL (2010) Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 23: 546–553. doi: 10.1097/qco.0b013e32833f0d3e
  11. 11. Page MGP, Heim J (2009) Prospects for the next anti-Pseudomonas drug. Curr Opin Pharm 9: 558–565. doi: 10.1016/j.coph.2009.08.006
  12. 12. Lazdunski A, Ventre I, Sturgis JN (2004) Regulatory circuits and communication in gram-negative bacteria. Nat Rev Immunol 2: 581–592. doi: 10.1038/nrmicro924
  13. 13. Camilli A, Bassler BL (2006) Bacterial small-molecule signaling pathways. Science 311: 1113–1116. doi: 10.1126/science.1121357
  14. 14. Rumbaugh KP, Kaufmann GF (2012) Exploitation of host signalling pathways by microbial quorum sensing signals. Curr Opin Microbiol 15: 162–168. doi: 10.1016/j.mib.2011.12.003
  15. 15. Li L, Hooi D, Chhabra SR, Pritchard D, Shaw PE (2004) Bacterial N-acylhomoserine lactone-induced apoptosis in breast carcinoma cells correlated with down-modulation of STAT3. Oncogene 23: 4894–4902. doi: 10.1038/sj.onc.1207612
  16. 16. Tateda K, Ishii Y, Horikawa M, Matsumoto T, Miyariri S, et al. (2003) The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect Immun 71: 5785–5793. doi: 10.1128/iai.71.10.5785-5793.2003
  17. 17. Kravchenko VV, Kaufmann GF, Mathison JC, Scott DA, Katz AZ, et al. (2006) N-(3-Oxo-acyl)homoserine lactones signal cell activation through a mechanism distinct from canonical pathogen-associated molecular pattern recognition receptor pathways. J Biol Chem 281: 28822–28830. doi: 10.1074/jbc.m606613200
  18. 18. Schwarzer C, Fu Z, Patanwala M, Hum L, Lopez-Guzman M, et al. (2012) Pseudomonas aeruginosa biofilm-associated homoserine lactone C12 rapidly activates apoptosis in airway epithelia. Cell Microbiol 14: 698–709. doi: 10.1111/j.1462-5822.2012.01753.x
  19. 19. Telford G, Wheeler D, Williams P, Tomkins PT, Appleby P, et al. (1998) The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-l-homoserine lactone has immunomodulatory activity. Infect Immun 66: 36–42.
  20. 20. Ritchie AJ, Jansson A, Stallberg J, Nilsson P, Lysaght P, et al. (2005) The Pseudomonas aeruginosa quorum-sensing molecule N-3-(oxododecanoyl)-l-homoserine lactone inhibits T-cell differentiation and cytokine production by a mechanism involving an early step in T-cell activation. Infect Immun 73: 1648–1655. doi: 10.1128/iai.73.3.1648-1655.2005
  21. 21. Kravchenko VV, Kaufmann GF, Mathison JC, Scott DA, Katz AZ, et al. (2008) Modulation of gene expression via disruption of NF-κB signaling by bacterial small molecules. Science 321: 259–263. doi: 10.1126/science.1156499
  22. 22. Smith RS, Kelly R, Iglewski BH, Phipps RP (2002) The Pseudomonas autoinducer N-(3-oxododecanoyl) homoserine lactone induced cyclooxygenase-2 and prostaglandin E2 production in human lung fibroblasts: implications for inflammation. J Immunol 169: 2636–2642. doi: 10.4049/jimmunol.169.5.2636
  23. 23. Mayer ML, Sheridan JA, Bolohmke CJ, Turvey SE, Hancock RE (2011) The Pseudomonas aeruginosa autoinducer 3O-C12 homoserine lactone provokes hyperinflammatory responses from cystic fibrosis airway epithelial cells. PLoS One 6: e16246. doi: 10.1371/journal.pone.0016246
  24. 24. Shiner EK, Terentyev D, Bryan A, Sennoune S, Martinez-Zaguilan R, et al. (2006) Pseudomonas aeruginosa autoinducer modulates host cell responses through calcium signalling. Cell Microbiol 8: 1601–1610. doi: 10.1111/j.1462-5822.2006.00734.x
  25. 25. Schwarzer C, Wong S, Shi J, Matthes E, Illek B, et al. (2010) Pseudomonas aeruginosa homoserine lactone activates store-operated cAMP and cystic fibrosis transmembrane regulator-dependent Cl secretion by human airway epithelia. J Biol Chem 285: 34850–34863. doi: 10.1074/jbc.m110.167668
  26. 26. Lee RJ, Xiong G, Kofonow JM, Chen B, Lysenko A, et al. (2012) T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest 122: 4145–4159. doi: 10.1172/jci64240
  27. 27. Jahoor A, Patel R, Bryan A, Do C, Krier J, et al. (2008) Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer. J Bacteriol 190: 4408–4415. doi: 10.1128/jb.01444-07
  28. 28. Davis BM, Jensen R, Williams P, O'Shea P (2010) The interaction of N-acylhomoserine lactone quorum sensing signalling molecules with biological membranes: Implications for inter-kingdom signalling. PLoS ONE 5: e13522. doi: 10.1371/journal.pone.0013522
  29. 29. Tait SWG, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621–632. doi: 10.1038/nrm2952
  30. 30. Tabas I, Ron D (2011) Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 13: 184–190. doi: 10.1038/ncb0311-184
  31. 31. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7: 880–885. doi: 10.1038/sj.embor.7400779
  32. 32. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 5: 897–904. doi: 10.1016/s1097-2765(00)80330-5
  33. 33. Han D, Lerner AG, Vande Walle L, Upton J-P, Xu W, et al. (2009) IRE1α kinase activation modes control alternative endoribonuclease outputs to determine divergent cell fates. Cell 138: 562–575. doi: 10.1016/j.cell.2009.07.017
  34. 34. Charlton TS, de Nys R, Netting A, Kumar N, Hentzer M, et al. (2000) A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectroscopy: application to a model of bacterial biofilm. Environ Microbiol 2: 530–541. doi: 10.1046/j.1462-2920.2000.00136.x
  35. 35. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519–529. doi: 10.1038/nrm2199
  36. 36. Yoshida H, Oku M, Suzuki M, Mori K (2006) pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J Cell Biol 172: 565–575. doi: 10.1083/jcb.200508145
  37. 37. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, et al. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664–666. doi: 10.1126/science.287.5453.664
  38. 38. Shore GC, Papa FR, Oakes SA (2011) Signaling cell death from the endoplasmic reticulum stress response. Curr Opin Cell Biol 23: 143–149. doi: 10.1016/j.ceb.2010.11.003
  39. 39. Lerner AG, Upton J-P, Praveen PVK, Ghosh R, Nakagawa Y, et al. (2012) IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremedial ER stress. Cell Metab 16: 250–264. doi: 10.1016/j.cmet.2012.07.007
  40. 40. Papandreou I, Denko NC, Olson M, van Melckebeke H, Lust S, et al. (2011) Identification of an Ire1α endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood 117: 1311–1314. doi: 10.1182/blood-2010-08-303099
  41. 41. Spiotto MT, Banh A, Papandreou I, Cao H, Galvez MG, et al. (2010) Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth. Cancer Res 70: 78–88. doi: 10.1158/0008-5472.can-09-2747
  42. 42. Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, et al. (2002) IRE1-mediated unconventional mRNA splicing and SP2-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev 16: 452–466. doi: 10.1101/gad.964702
  43. 43. Wang Y, Shen J, Arenzana N, Tirasophon W, Kaufman RJ, et al. (2000) Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J Biol Chem 275: 27013–27020.
  44. 44. Lee A-H, Iwakowshi NN, Glimcher LH (2003) XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded response. Mol Cell Biol 23: 7448–7459. doi: 10.1128/mcb.23.21.7448-7459.2003
  45. 45. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101: 6062–6067. doi: 10.1073/pnas.0400782101
  46. 46. Smith RS, Harris SG, Phipps R, Iglewski BH (2002) The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl) homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol 184: 1132–1139. doi: 10.1128/jb.184.4.1132-1139.2002
  47. 47. Sriramulu DD, Lunsdorf H, Lam JS, Romling U (2005) Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for cystic fibrosis lung. J Med Microbiol 54: 667–676. doi: 10.1099/jmm.0.45969-0
  48. 48. Kravchenko VV, Kaufmann GF (2013) Bacterial inhibition of inflammatory responses via TLR-independent mechanisms. Cell Microbiol 15: 527–536. doi: 10.1111/cmi.12109
  49. 49. Acosta-Alvear D, Zhou Y-Y, Blais A, Tsikitis M, Lents NH, et al. (2007) XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell 27: 53–66. doi: 10.1016/j.molcel.2007.06.011
  50. 50. Masaki T, Yoshida M, Noguchi S (1999) Targeted disruption of CRE-binding factor TREB5 gene leads to cellular necrosis in cardiac myocytes at the embryonic stage. Biochem Biophys Res Commun 261: 350–356. doi: 10.1006/bbrc.1999.0972
  51. 51. Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, et al. (2000) An essential role in liver development for the transcription factor XBP-1. Genes Dev 14: 152–157.
  52. 52. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, et al. (2001) Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300–307. doi: 10.1038/35085509
  53. 53. Lee A-H, Chu GC, Iwakoshi NN, Glimcher LH (2005) XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands. EMBO J 24: 4368–4380. doi: 10.1038/sj.emboj.7600903
  54. 54. Kaser A, Lee A-H, Franke A, Glickman JN, Zeissig S, et al. (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134: 743–756. doi: 10.1016/j.cell.2008.07.021
  55. 55. Richardson CE, Kooistra T, Kim DH (2010) An essential role for XBP-1 in host protection against immune activation in C. elegans. Nature 463: 1092–1095. doi: 10.1038/nature08762
  56. 56. Zeng L, Zampetaki A, Margariti A, Pepe AE, Alam S, et al. (2009) Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow. Proc Natl Acad Sci USA 106: 8326–8331. doi: 10.1073/pnas.0903197106
  57. 57. Allagnat F, Christulia F, Ortis F, Pirot P, Lortz S, et al. (2010) Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic β cell dysfunction and apoptosis. Diabetologia 53: 1120–1130. doi: 10.1007/s00125-010-1699-7
  58. 58. Martinon F, Chen X, Lee A-H, Glimcher LH (2010) TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 11: 411–418. doi: 10.1038/ni.1857
  59. 59. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D (2000) Dynamic interactions of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2: 326–332. doi: 10.1038/35014014
  60. 60. Samuel CE (1993) The eIF-2α protein kinases, regulators of translation in eukaryotes from yeast to humans. J Biol Chem 268: 7603–7606.
  61. 61. Hebbar N, Wang C, Rangnekar VM (2012) Mechanisms of apoptosis by the tumor suppressor Par-4. J Cell Physiol 227: 3715–3721. doi: 10.1002/jcp.24098
  62. 62. Pomini AM, Marsaioli AJ (2008) Absolute configuration and antimicrobial activity of acylhomoserine lactones. J Nat Prod 71: 1032–1036. doi: 10.1021/np800127b
  63. 63. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, et al. (2002) IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415: 92–96. doi: 10.1038/415092a